Physician profile
Jeffrey W Kolff
NPI 1457462293
$330.84
in general payments reported to CMS, 2019-2025
9 companies · $52.17 in 2025
The $52.17 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.07 · 2020: $21.44 · 2021: $37.19 · 2023: $60.39 · 2024: $143 · 2025: $52.17.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $255.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $255.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $136.95 | 2023-2025 | Oasis Micro, Oasis, Stravix Pl |
| Intuitive Surgical, INC. | $37.19 | 2021 | |
| Acera Surgical, INC. | $31.82 | 2024 | Restrata Wound Matrix |
| Ethicon US, LLC | $26.12 | 2023 | Harmonic |
| Davol INC. | $24.47 | 2025 | Phasix Mesh |
| Pacira Pharmaceuticals Incorporated | $22.38 | 2024 | Exparel |
| Z-Medica, LLC | $21.44 | 2020 | |
| Shire North American Group INC | $17.07 | 2019 | |
| Tela Bio, INC. | $13.40 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Kolff listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.